share_log

Cantor Fitzgerald Reinstates Neutral on TherapeuticsMD, Announces $5 Price Target

Cantor Fitzgerald Reinstates Neutral on TherapeuticsMD, Announces $5 Price Target

坎特·菲茨杰拉德恢復中立治療 SMD,宣布 5 美元目標價格
Benzinga Real-time News ·  2023/01/11 07:47

Cantor Fitzgerald analyst Louise Chen reinstates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and announces $5 price target.

Cantor Fitzgerald分析師Louise Chen恢復TreateuticsMD(納斯達克:TXMD)的中性,並宣佈5美元的目標價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論